Literature DB >> 2298012

Pretreatment with pentoxifylline improves the hemodynamic and histologic changes and decreases neutrophil adhesiveness in a pig fecal peritonitis model.

D Tighe1, R Moss, J Hynd, S Boghossian, N al-Saady, M F Heath, E D Bennett.   

Abstract

We investigated pentoxifylline (PTF) as a pretreatment of septic syndrome in pigs with fecal peritonitis. In the untreated group there was a progressive decrease in mean arterial pressure (MAP), cardiac output, mean pulmonary artery wedge pressure (WP), and a progressive rise in mean pulmonary artery pressure (MPAP), pulmonary vascular resistance (PVR), systemic vascular resistance (SVR), heart rate (HR), and core temperature (T). In those pigs given PTF there was a significantly smaller increase in SVR throughout and in PVR after 270 min. No significant differences were seen in MAP, MPAP, WP, HR, and T. Neutrophil adhesiveness did not change in the untreated group. However, it decreased markedly with PTF, both before and after peritonitis induction. Electron microscopy of the lungs, liver, and spleen in the test group showed severe damage, with endothelial disruption, capillary or sinusoidal occlusion, leukostasis, and neutrophil degranulation. Pretreatment with PTF attenuated these changes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2298012     DOI: 10.1097/00003246-199002000-00012

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  11 in total

1.  A narrow range, medium molecular weight pentastarch reduces structural organ damage in a hyperdynamic porcine model of sepsis.

Authors:  A R Webb; R F Moss; D Tighe; M G Mythen; N al-Saady; A E Joseph; E D Bennett
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

2.  The effects of dobutamine, dopexamine and fluid on hepatic histological responses to porcine faecal peritonitis.

Authors:  A R Webb; R F Moss; D Tighe; N al-Saady; E D Bennett
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

3.  Pentoxifylline does not improve outcome in a murine model for the multiple-organ dysfunction syndrome.

Authors:  T J H Volman; R J A Goris; T Hendriks
Journal:  Intensive Care Med       Date:  2005-02-15       Impact factor: 17.440

4.  Influence of pentoxifylline on cytokine levels and inflammatory parameters in septic shock.

Authors:  T Staudinger; E Presterl; W Graninger; G J Locker; S Knapp; K Laczika; G Klappacher; B Stoiser; A Wagner; P Tesinsky; H Kordova; M Frass
Journal:  Intensive Care Med       Date:  1996-09       Impact factor: 17.440

5.  Pentoxifylline attenuates ischemia/reperfusion injury to the small intestine in the rat.

Authors:  R Udassin; A Vromen; D Seror; Y Haskel
Journal:  Pediatr Surg Int       Date:  2013-09-21       Impact factor: 1.827

Review 6.  Intensive care.

Authors:  S Sinclair; M Singer
Journal:  Postgrad Med J       Date:  1993-05       Impact factor: 2.401

7.  Therapeutic potential for cytokine antagonists: Thalidomide and pentoxifylline in Hansen's disease.

Authors:  T C Peterson
Journal:  Can J Infect Dis       Date:  1995-01

Review 8.  Blood-brain barrier breakdown in septic encephalopathy and brain tumours.

Authors:  D C Davies
Journal:  J Anat       Date:  2002-06       Impact factor: 2.610

Review 9.  [Microcirculation of intensive care patients. From the physiology to the bedside].

Authors:  H Knotzer; W Hasibeder
Journal:  Anaesthesist       Date:  2008-02       Impact factor: 1.041

10.  Pentoxifylline treatment of sepsis of premature infants: preliminary clinical observations.

Authors:  R Lauterbach; D Pawlik; B Tomaszczyk; B Cholewa
Journal:  Eur J Pediatr       Date:  1994-09       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.